167 related articles for article (PubMed ID: 27936014)
1. Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion.
Hartman MH; Vreeswijk-Baudoin I; Groot HE; van de Kolk KW; de Boer RA; Mateo Leach I; Vliegenthart R; Sillje HH; van der Harst P
PLoS One; 2016; 11(12):e0167195. PubMed ID: 27936014
[TBL] [Abstract][Full Text] [Related]
2. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.
Kobara M; Noda K; Kitamura M; Okamoto A; Shiraishi T; Toba H; Matsubara H; Nakata T
Cardiovasc Res; 2010 Aug; 87(3):424-30. PubMed ID: 20211866
[TBL] [Abstract][Full Text] [Related]
3. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
[TBL] [Abstract][Full Text] [Related]
6. Increased fibrosis and progression to heart failure in MRL mice following ischemia/reperfusion injury.
Smiley D; Smith MA; Carreira V; Jiang M; Koch SE; Kelley M; Rubinstein J; Jones WK; Tranter M
Cardiovasc Pathol; 2014; 23(6):327-34. PubMed ID: 25035060
[TBL] [Abstract][Full Text] [Related]
7. Sodium 4-Phenylbutyrate Attenuates Myocardial Reperfusion Injury by Reducing the Unfolded Protein Response.
Takatori O; Usui S; Okajima M; Kaneko S; Ootsuji H; Takashima SI; Kobayashi D; Murai H; Furusho H; Takamura M
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):283-292. PubMed ID: 27909014
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
[TBL] [Abstract][Full Text] [Related]
9. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
10. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
11. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
[TBL] [Abstract][Full Text] [Related]
12. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion.
Kristen AV; Ackermann K; Buss S; Lehmann L; Schnabel PA; Haunstetter A; Katus HA; Hardt SE
Cardiovasc Pathol; 2013; 22(4):280-6. PubMed ID: 23410819
[TBL] [Abstract][Full Text] [Related]
15. A Model of Blood Component-Heart Interaction in Cardiac Ischemia-Reperfusion Injury using a Langendorff-Based Ex Vivo Assay.
Muessig JM; Kaya S; Moellhoff L; Noelle J; Hidalgo Pareja L; Masyuk M; Gerdes N; Pernow J; Kelm M; Jung C
J Cardiovasc Pharmacol Ther; 2020 Mar; 25(2):164-173. PubMed ID: 31495204
[TBL] [Abstract][Full Text] [Related]
16. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
[TBL] [Abstract][Full Text] [Related]
17. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β blockade improves left ventricular systolic/diastolic function and restores contractility reserve in severe ischemic cardiomyopathy in the mouse.
Toldo S; Mezzaroma E; Bressi E; Marchetti C; Carbone S; Sonnino C; Van Tassell BW; Abbate A
J Cardiovasc Pharmacol; 2014 Jul; 64(1):1-6. PubMed ID: 25006675
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism.
Reichert K; Pereira do Carmo HR; Galluce Torina A; Diógenes de Carvalho D; Carvalho Sposito A; de Souza Vilarinho KA; da Mota Silveira-Filho L; Martins de Oliveira PP; Petrucci O
PLoS One; 2016; 11(11):e0166845. PubMed ID: 27880844
[TBL] [Abstract][Full Text] [Related]
20. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
